Back to Browse Categories
Related journals you may be interested in:
Recent articles:
- 10 records -
The Potential of the lncRNAs ADAMTSL4-AS1, AC067931 and SOCS2-AS1 in Peripheral Blood Mononuclear Cells as Novel Diagnostic Biomarkers for Hepatitis B Virus-Associated Hepatocellular Carcinoma
Guan W, Zhang C, Miao T, Dong C, Li L, Yuan X, Zhao D, Ai R, Zhang X, Sun M, Kang H, Nan Y
Journal of Hepatocellular Carcinoma 2024, 11:1221-1233
Published Date: 27 June 2024
![Article collection](assets/img/article_icons/thematic-series.png)
The Influence of Visceral Adiposity on Overall Survival: Exploring “Obesity Paradox” Among Hepatocellular Carcinoma Patients Who Receiving Immunotherapy
Zhou Y, Ouyang J, Yang H, Wang Z, Yang Y, Li Q, Zhao H, Zhou J, Li Q
Journal of Hepatocellular Carcinoma 2024, 11:1193-1206
Published Date: 24 June 2024
![Article collection](assets/img/article_icons/thematic-series.png)
Radiomics-Based Prediction of Microvascular Invasion Grade in Nodular Hepatocellular Carcinoma Using Contrast-Enhanced Magnetic Resonance Imaging
Zhang Z, Jia XF, Chen XY, Chen YH, Pan KH
Journal of Hepatocellular Carcinoma 2024, 11:1185-1192
Published Date: 21 June 2024
GDF15: Immunomodulatory Role in Hepatocellular Carcinoma Pathogenesis and Therapeutic Implications
Du YN, Zhao JW
Journal of Hepatocellular Carcinoma 2024, 11:1171-1183
Published Date: 19 June 2024
PD-1 Inhibitors Combined with Tyrosine Kinase Inhibitors with or without Hepatic Artery Infusion Chemotherapy for the First-Line Treatment of HBV-Related Advanced Hepatocellular Carcinoma: A Retrospective Study
Wang D, Zhang Z, Yang L, Zhao L, Liu Z, Lou C
Journal of Hepatocellular Carcinoma 2024, 11:1157-1170
Published Date: 18 June 2024
Research Progress on the Role of Epigenetic Methylation Modification in Hepatocellular Carcinoma
Wang J, Gao W, Yu H, Xu Y, Bai C, Cong Q, Zhu Y
Journal of Hepatocellular Carcinoma 2024, 11:1143-1156
Published Date: 17 June 2024
Establishing and Externally Validating a Hemoglobin, Albumin, Lymphocyte, and Platelet (HALP) Score-Based Nomogram for Predicting Early Recurrence in BCLC Stage 0/A Hepatocellular Carcinoma Patients After Radical Liver Resection: A Multi-Center Study
Liu X, Qiu Z, Ndhlovu E, Wan Y, Sun H, Wang S, Cao Y, Zhu P
Journal of Hepatocellular Carcinoma 2024, 11:1127-1141
Published Date: 14 June 2024
Incorporating Inflammatory Markers and Clinical Indicators into a Predictive Model of Single Small Hepatocellular Carcinoma Recurrence After Primary Locoregional Treatments
Qiao W, Xiong Y, Li K, Jin R, Zhang Y
Journal of Hepatocellular Carcinoma 2024, 11:1113-1125
Published Date: 13 June 2024
Circ_0007386 Promotes the Progression of Hepatocellular Carcinoma Through the miR-507/ CCNT2 Axis
![](cr_data/cache/article_graphical_abstract/s459633/graphical_abstract.jpg)
Feng Y, Liang L, Jia W, Wang J, Xu C, Zhu D, Xu B, Zhao W, Ling X, Zhou Y, Kong L, Ding W
Journal of Hepatocellular Carcinoma 2024, 11:1095-1112
Published Date: 13 June 2024
Transarterial Chemoembolization Combined with Atezolizumab Plus Bevacizumab versus Transarterial Chemoembolization Alone in Intermediate‐stage Hepatocellular Carcinoma: A Multicenter Retrospective Study
Zheng Y, Xiang Y, Shi H, Lin Z, Cheng S, Zhu J
Journal of Hepatocellular Carcinoma 2024, 11:1079-1093
Published Date: 12 June 2024